Part 1/3 Unmet needs – poorly treated lung diseases Sweden has been a strong player in the field of inhaled medicines for several decades. Today, a range of efficacious medicines are available for asthma and COPD, among others developed by AstraZeneca. This series of three seminars initiates the discussion around other, poorly treated lung diseases. […]